J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 64 (1983), 1649-1656; DOI 10.1099/0022-1317-64-8-1649
© 1983 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wunner, W. H.
Right arrow Articles by Wiktor, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wunner, W. H.
Right arrow Articles by Wiktor, T. J.
Agricola
Right arrow Articles by Wunner, W. H.
Right arrow Articles by Wiktor, T. J.

Rabies Subunit Vaccines

William H. Wunner, Bernhard Dietzschold, Peter J. Curtis and Tadeusz J. Wiktor

The Wistar Institute, 36th Street at Spruce, Philadelphia, Pennsylvania 19104, U.S.A.

Conclusions: The secondary and tertiary structures of the rabies virus spike G protein are important for its ability to induce VN antibodies and confer immunity to the host. For a subunit peptide vaccine to be as effective as the native spike G protein, it would appear that the amino acid sequence comprising the antigenic determinant for VN antibody binding must be made to fold properly even when deprived of its native support structure. Since CNBr peptides have retained at least some of their antigenicity for binding antibodies from hyperimmune serum but not monoclonal VN antibodies, and their immunogenicity, then synthetic peptides containing corresponding sequences should show similar activities. Additionally, determinants that might be necessary for stimulating T lymphocytes would have to be built into the synthetic peptide preparation. It would also appear that a properly folded peptide might have to be aggregated into suitably large particles for it to achieve its full protective effect. Adjuvants may serve in this capacity to enhance the immune response to relevant peptides and thus improve the immunogenicity of a subunit vaccine that ultimately protects animals and humans against rabies virus infection.

Keywords: rabies virus, glycoprotein, peptide fragments




This article has been cited by other articles:


Home page
GlycobiologyHome page
B. S. Wojczyk, N. Takahashi, M. T. Levy, D. W. Andrews, W. R. Abrams, W. H. Wunner, and S. L. Spitalnik
N-glycosylation at one rabies virus glycoprotein sequon influences N-glycan processing at a distant sequon on the same molecule
Glycobiology, June 1, 2005; 15(6): 655 - 666.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Kasturi, J. R. Eshleman, W. H. Wunner, and S. H. Shakin-Eshleman
The Hydroxy Amino Acid in an Asn-X-Ser/Thr Sequon Can Influence N-Linked Core Glycosylation Efficiency and the Level of Expression of a Cell Surface Glycoprotein
J. Biol. Chem., June 16, 1995; 270(24): 14756 - 14761.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1983 by the Society for General Microbiology.